In January 1994, the MTA officially debuted MetroCards as part of its effort to phase out subway tokens. Now, the transit agency is working toward having a completely contactless fare payment system.
Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results